Anbio Biotechnology Statistics
Total Valuation
NNNN has a market cap or net worth of $331.38 million. The enterprise value is $321.07 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NNNN has 43.89 million shares outstanding. The number of shares has decreased by -70.28% in one year.
Current Share Class | 43.89M |
Shares Outstanding | 43.89M |
Shares Change (YoY) | -70.28% |
Shares Change (QoQ) | -70.28% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 39.69M |
Valuation Ratios
The trailing PE ratio is 73.75.
PE Ratio | 73.75 |
Forward PE | n/a |
PS Ratio | 33.60 |
Forward PS | n/a |
PB Ratio | 17.34 |
P/TBV Ratio | 17.99 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 74.15 |
EV / Sales | 33.79 |
EV / EBITDA | n/a |
EV / EBIT | 77.59 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 35.56
Current Ratio | 35.56 |
Quick Ratio | 28.28 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 26.64% and return on invested capital (ROIC) is 15.92%.
Return on Equity (ROE) | 26.64% |
Return on Assets (ROA) | 15.05% |
Return on Invested Capital (ROIC) | 15.92% |
Return on Capital Employed (ROCE) | 22.47% |
Revenue Per Employee | $351,928 |
Profits Per Employee | $160,360 |
Employee Count | 27 |
Asset Turnover | 0.55 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 68.34 |
Average Volume (20 Days) | 181,352 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NNNN had revenue of $9.50 million and earned $4.33 million in profits. Earnings per share was $0.10.
Revenue | 9.50M |
Gross Profit | 5.47M |
Operating Income | 4.14M |
Pretax Income | 4.33M |
Net Income | 4.33M |
EBITDA | n/a |
EBIT | 4.14M |
Earnings Per Share (EPS) | $0.10 |
Full Income Statement Balance Sheet
The company has $10.31 million in cash and n/a in debt, giving a net cash position of $10.31 million or $0.23 per share.
Cash & Cash Equivalents | 10.31M |
Total Debt | n/a |
Net Cash | 10.31M |
Net Cash Per Share | $0.23 |
Equity (Book Value) | 18.42M |
Book Value Per Share | 0.44 |
Working Capital | 18.24M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -634,089 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 57.61%, with operating and profit margins of 43.55% and 45.57%.
Gross Margin | 57.61% |
Operating Margin | 43.55% |
Pretax Margin | 45.57% |
Profit Margin | 45.57% |
EBITDA Margin | n/a |
EBIT Margin | 43.55% |
FCF Margin | n/a |